DEA Sets Quota to Limit Amount of Opioids Manufactured in 2017

Drug Industry Daily
A A
The DEA has reduced the amount of Schedule II opiate and opioid medications that can be manufactured in the U.S. next year by at least 25 percent.

To View This Article:

Login

Subscribe To Drug Industry Daily